Usefulness of a standard 12-lead electrocardiogram to predict the eligibility for a subcutaneous defibrillator based on the automatic screening tool

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Rafi Sakhi

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail

Transient malfunctions of contemporary implantable cardioverter-defibrillators ongoing oncologic radiotherapy: a randomized, real-time, in-vitro observation

Doctor E. Di Girolamo (Lanciano, IT)

Presentation thumbnail

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

Doctor T. Lubimceva (Saint Petersburg, RU)

Abstract Slides

Presentation thumbnail

Predictors of major adverse events after ICD replacement over 12-month follow-up: insight from the DECODE registry

Doctor M. Bertini (Ferrara, IT)

Presentation thumbnail

Inducibility of ventricular fibrillation during subcutaneous implantable cardioverter - defibrillator implantation

Doctor V. Bianchi (Naples, IT)

Abstract Slides

Presentation thumbnail

In-hospital and long-term prognosis in patients after the implantation of implantable cardioverter-defibrillators and cardiac resynchronization therapy. Ten-year results of the SILCARD register.

Doctor D. Pres (Zabrze, PL)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePosters 6: latest in ICD therapy and the risk of sudden cardiac death

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

Implantable cardioverter-defibrillator

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Session

Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources